Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linaclotide vs Placebo in Pediatric Functional Constipation (Ages 2–5)
2022-501946-31-00Phase 3Completed
- Sponsor
- AbbVie Inc.
- Start
- Aug 2023
- Modality
- Peptides
- Countries
- 4
01
Overview
Phase 3, randomised, double-blind trial in functional constipation (FC) comparing Linaclotide with Placebo (2 arms). Primary endpoint: Change from baseline in 12-week SBM frequency rate. Started Aug 2023; status: completed.
02
Drugs
linaclotide
03
Conditions
functional constipation (FC)
Beyond the preview
Go deeper on 2022-501946-31-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-501946-31-00.